Artificial intelligence (AI) is rapidly reshaping the landscape of leukemia diagnosis, offering new possibilities for earlier detection, more precise classification, and improved patient care, ...
GE HealthCare’s Recon DL is claimed to be the first mammography technology to use deep learning alongside iterative ...
GE HealthCare (Nasdaq: GEHC) announced today that it has received FDA Premarket Authorization for Pristina Recon DL, an ...
AI everyday life enhancements make daily routines smarter with practical uses and surprising benefits for everyone.